No Data
No Data
Hangzhou TianMuShan Pharmaceutical Re-Registers Pearl Eye Drops
ST Visionox (600671.SH) appointed Sun Xuejian as general manager.
ST Medicines (600671.SH) announced that the board of directors of the company recently received the written resignation report of the general manager Xu Xuyu...
Special treat pharmaceutical (600671.SH): received notice of drug re-registration approval.
On August 2, Gelon Hui reported that Special Treat Pharmaceutical (stock code: 600671.SH) has recently received the "Drug Re-registration Approval Notice" issued and approved by the Zhejiang Province Food and Drug Administration. 1. The main ingredients of Pearl Bright Eye Drops are pearl liquid and natural borneol, which are colorless and clear liquids with a fragrant odor. Its main functions are clearing heat and fire, nourishing liver and brightening eyes, suitable for visual fatigue and chronic conjunctivitis. 2. The main ingredient of Ribavirin Eye Drops is Ribavirin, whose chemical name is: 1-β-D-furan nucleoside-1,2,4-triazole-3-carboxamide; it is a colorless and clear liquid. It is mainly used to treat herpes simplex virus.
Hangzhou Medical Security Association Ends Tianmushan Pharmaceutical Unit's Medical Insurance; Shares Down 5%
Special treat Vision Medicine (600671.SH): Its subsidiary received a medical insurance agreement disposal decision.
On July 17th, Gelonhui reported that ST Medicine (600671.SH) announced that its subsidiary, Hangzhou Sanshentai Traditional Chinese Medicine Clinic Co., Ltd. (referred to as 'Sanshentai TCM Clinic'), recently received an 'Agreement Processing Decision' from the Hangzhou Medical Security Management Service Center. The Hangzhou Medical Security Management Service Center conducted an on-site inspection of Sanshentai TCM Clinic and found problems such as medical projects not being recorded as required, doctors not signing in according to regulations, and some patients not receiving treatment that matched their conditions. The above actions violate the relevant rules of the 'Hangzhou Medical Security Designated Medical Institutions Service Agreement' (version 2023).
As of July 10th, 2024, the number of shareholders of ST Medicine (600671.SH) is 5,966 households.
On July 16th, Gelunhui reported that as of July 10th, 2024, the number of shareholders of ST Muyao (600671.SH) was 5966.
No Data